MIT Technology Review Subscribe

Brain Stimulation Controls Seizures in Rats

A new device could help epilepsy patients control unpredictable seizures when medications don’t work.

A “brain pacemaker” has been shown to control epilepsy in rats by responding to abnormal electrical patterns in the brain as they happen. The device, reported in today’s issue of Science, is less invasive than some other seizure-zapping technologies in development—it does not need to be implanted into the brain tissue. Instead, it sits on the brain’s surface. And because the device is only activated in response to seizures, it does not share the risk of causing brain-changing side effects carried by continuously stimulating devices.

Some 30 to 40 percent of epilepsy patients do not respond to medication; these kinds of self-regulating devices could provide these patients with a way to control their seizures as they happen.

Advertisement

As reported by HealthDay:

This story is only available to subscribers.

Don’t settle for half the story.
Get paywall-free access to technology news for the here and now.

Subscribe now Already a subscriber? Sign in
You’ve read all your free stories.

MIT Technology Review provides an intelligent and independent filter for the flood of information about technology.

Subscribe now Already a subscriber? Sign in

It works like a ping-pong game,” explained study author Dr. Gyorgy Buzsaki, a professor of neural science at New York University. “Every time a ball is coming your way, you apply an interfering pattern to whack it away.”

Technology Review reported on a version of this kind of treatment in 2007 that requires deeper implantation into the brain (see “Zapping Seizures Away”). The company behind that technology, Neuropace, recently announced that it is seeking FDA approval for the treatment, which they’ve already tested in 191 epilepsy patients.

This is your last free story.
Sign in Subscribe now

Your daily newsletter about what’s up in emerging technology from MIT Technology Review.

Please, enter a valid email.
Privacy Policy
Submitting...
There was an error submitting the request.
Thanks for signing up!

Our most popular stories

Advertisement